SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Isabelle Beaulieu-Boire, Anthony E. Lang, Behavioral effects of levodopa, Movement Disorders, 2015, 30, 1
  2. 2
    Chin-Hsien Lin, Ruey-Meei Wu, Biomarkers of cognitive decline in Parkinson's disease, Parkinsonism & Related Disorders, 2015, 21, 5, 431

    CrossRef

  3. 3
    Jacopo Vittoriano Bizzarri, Giancarlo Giupponi, Ignazio Maniscalco, Patrizia Schroffenegger, Andreas Conca, Hans Peter Kapfhammer, Parkinson-Krankheit und Psychosen, neuropsychiatrie, 2015, 29, 1, 1

    CrossRef

  4. 4
    Artur F Schumacher-Schuh, Carlos RM Rieder, Mara H Hutz, Parkinson's disease pharmacogenomics: new findings and perspectives, Pharmacogenomics, 2014, 15, 9, 1253

    CrossRef

  5. 5
    M. Kuoppamäki, M. Vahteristo, J. Ellmén, K. Kieburtz, Pooled analysis of phase III with entacapone in Parkinson's disease, Acta Neurologica Scandinavica, 2014, 130, 4
  6. 6
    Thien Thien Lim, Kelvin L. Chou, Hubert H. Fernandez, Handbook of Parkinson’s Disease, 2013,

    CrossRef

  7. 7
    Thien Lim, Kelvin Chou, Hubert Fernandez, Handbook of Parkinson's Disease, Fifth Edition, 2013,

    CrossRef

  8. 8
    Kurt A. Jellinger, Cerebral correlates of psychotic syndromes in neurodegenerative diseases, Journal of Cellular and Molecular Medicine, 2012, 16, 5
  9. 9
    Kurt A Jellinger, Neurobiology of cognitive impairment in Parkinson’s disease, Expert Review of Neurotherapeutics, 2012, 12, 12, 1451

    CrossRef

  10. 10
    Byron Creese, Clive Ballard, Dag Aarsland, Elisabet Londos, Sally Sharp, Emma Jones, No association of COMT val158met polymorphism and psychotic symptoms in Lewy body dementias, Neuroscience Letters, 2012, 531, 1, 1

    CrossRef

  11. 11
    Stewart A. Factor, N. Kyle Steenland, Donald S. Higgins, Eric S. Molho, Denise M. Kay, Jennifer Montimurro, Ami R. Rosen, Cyrus P. Zabetian, Haydeh Payami, Disease-related and genetic correlates of psychotic symptoms in Parkinson's disease, Movement Disorders, 2011, 26, 12
  12. 12
    Jennifer G. Goldman, New Thoughts on Thought Disorders in Parkinson's Disease: Review of Current Research Strategies and Challenges, Parkinson's Disease, 2011, 2011, 1

    CrossRef

  13. 13
    Rivka Inzelberg, Anna Polyniki, Are genetic and sporadic Parkinson's disease patients equally susceptible to develop dementia?, Journal of the Neurological Sciences, 2010, 289, 1-2, 23

    CrossRef

  14. 14
    C. H. Williams-Gray, A. Goris, M. Saiki, T. Foltynie, D. A. S. Compston, S. J. Sawcer, R. A. Barker, Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson’s Disease, Journal of Neurology, 2009, 256, 3, 493

    CrossRef

  15. 15
    Christopher G. Goetz, Murat Emre, Bruno Dubois, Parkinson's disease dementia: Definitions, guidelines, and research perspectives in diagnosis, Annals of Neurology, 2008, 64, S2
  16. You have free access to this content16
    Murat Emre, Dag Aarsland, Richard Brown, David J. Burn, Charles Duyckaerts, Yoshikino Mizuno, Gerald Anthony Broe, Jeffrey Cummings, Dennis W. Dickson, Serge Gauthier, Jennifer Goldman, Christopher Goetz, Amos Korczyn, Andrew Lees, Richard Levy, Irene Litvan, Ian McKeith, Warren Olanow, Werner Poewe, Niall Quinn, Christina Sampaio, Eduardo Tolosa, Bruno Dubois, Clinical diagnostic criteria for dementia associated with Parkinson's disease, Movement Disorders, 2007, 22, 12
  17. 17
    Maurits EL Arbouw, Jeroen PP van Vugt, Toine CG Egberts, Henk-Jan Guchelaar, Pharmacogenetics of antiparkinsonian drug treatment: a systematic review, Pharmacogenomics, 2007, 8, 2, 159

    CrossRef

  18. 18
    Barbara C. van Munster, Johanna C. Korevaar, Sophia E. de Rooij, Marcel Levi, Aeilko H. Zwinderman, The association between delirium and the apolipoprotein E ϵ4 allele in the elderly, Psychiatric Genetics, 2007, 17, 5, 261

    CrossRef

  19. 19
    Alexander I. Tröster, Julie A. Fields, Anthony M. Paolo, William C. Koller, Absence of the apolipoprotein E ε4 allele is associated with working memory impairment in Parkinson's disease, Journal of the Neurological Sciences, 2006, 248, 1-2, 62

    CrossRef

  20. 20
    Current awareness in geriatric psychiatry, International Journal of Geriatric Psychiatry, 2006, 21, 3
  21. 21
    Lisa Skipper, Jian-Jun Liu, Eng-King Tan, Polymorphisms in candidate genes: implications for the current treatment of Parkinson’s disease, Expert Opinion on Pharmacotherapy, 2006, 7, 7, 849

    CrossRef

  22. 22
    Thomas W Meeks, Susan A Ropacki, Dilip V Jeste, The neurobiology of neuropsychiatric syndromes in dementia, Current Opinion in Psychiatry, 2006, 19, 6, 581

    CrossRef

  23. 23
    Thomas M. Hyde, Maria A. Ron, The Secondary Schizophrenias,